A STAR Is Born: A New Approach to Assessing Chronic Obstructive Pulmonary Disease Severity

por Calverley, Peter M. A.
Publicado 2023

Guidance for the Better Care of Patients with Chronic Obstructive Pulmonary Disease

por Calverley, Peter M. A.
Publicado 2020

Defining Airflow Obstruction: More Data, Further Clarity

por Calverley, Peter M. A.
Publicado 2020

COPD in the time of COVID-19

por Calverley, Peter M.A.
Publicado 2021

The Management of Severe Chronic Obstructive Pulmonary Disease

por Calverley, Peter M A
Publicado 1999

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time

por Calverley, Peter M. A., Walker, Paul P.
Publicado 2019

ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against

por Calverley, Peter M. A., Walker, Paul Phillip
Publicado 2021

Understanding the People Excluded from Chronic Obstructive Pulmonary Disease Clinical Trials

por Krishnan, Jamuna K., Calverley, Peter M. A.
Publicado 2022

Exercise performance and differences in physiological response to pulmonary rehabilitation in severe chronic obstructive pulmonary disease with hyperinflation

por de Albuquerque, André Luis Pereira, Quaranta, Marco, Chakrabarti, Biswajit, Aliverti, Andrea, Calverley, Peter M.
Publicado 2016

Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials

por Calverley, Peter M. A., Könen-Bergmann, Michael, Richard, Frank, Bell, Susan, Hohlfeld, Jens M.
Publicado 2016

Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial

por Dusser, Daniel, Wise, Robert A, Dahl, Ronald, Anzueto, Antonio, Carter, Kerstine, Fowler, Andy, Calverley, Peter M
Publicado 2016

Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease

por Jenkins, Christine R., Postma, Dirkje S., Anzueto, Antonio R., Make, Barry J., Peterson, Stefan, Eriksson, Göran, Calverley, Peter M.
Publicado 2015

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial

por Dahl, Ronald, Calverley, Peter M A, Anzueto, Antonio, Metzdorf, Norbert, Fowler, Andy, Mueller, Achim, Wise, Robert, Dusser, Daniel
Publicado 2015

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

por Calverley, Peter M, Postma, Dirkje S, Anzueto, Antonio R, Make, Barry J, Eriksson, Göran, Peterson, Stefan, Jenkins, Christine R
Publicado 2016

Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD

por Calverley, Peter M. A., Rennard, Stephen I., Clerisme-Beaty, Emmanuelle, Metzdorf, Norbert, Zubek, Valentina Bayer, ZuWallack, Richard
Publicado 2016

Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials

por Rennard, Stephen I, Sun, Shawn X, Tourkodimitris, Stavros, Rowe, Paul, Goehring, Udo M, Bredenbröker, Dirk, Calverley, Peter M A
Publicado 2014

A score to predict short-term risk of COPD exacerbations (SCOPEX)

por Make, Barry J, Eriksson, Göran, Calverley, Peter M, Jenkins, Christine R, Postma, Dirkje S, Peterson, Stefan, Östlund, Ollie, Anzueto, Antonio
Publicado 2015

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

por Calverley, Peter M, Eriksson, Göran, Jenkins, Christine R, Anzueto, Antonio R, Make, Barry J, Persson, Anders, Fagerås, Malin, Postma, Dirkje S
Publicado 2016

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials

por Eriksson, Göran, Calverley, Peter M, Jenkins, Christine R, Anzueto, Antonio R, Make, Barry J, Lindberg, Magnus, Fagerås, Malin, Postma, Dirkje S
Publicado 2017

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

por Watz, Henrik, Tetzlaff, Kay, Magnussen, Helgo, Mueller, Achim, Rodriguez-Roisin, Roberto, Wouters, Emiel F. M., Vogelmeier, Claus, Calverley, Peter M. A.
Publicado 2018